Skip to content

Clinical trials

Phase 3 Dermatitis, Atopic trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis, Atopic Phase: Phase 3 Country / region: Italy Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20042
20101
20111
20131
20142
20172
201811
20193
20202
20222
20234
20247
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Active, not recruiting6
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie8
Pfizer5
Amgen4
Astellas Pharma Inc4
Eli Lilly and Company4
Sanofi4
Incyte Corporation3
LEO Pharma3
Regeneron Pharmaceuticals3
ASST Fatebenefratelli Sacco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis, Atopic41
Eczema12
Dermatitis2
Genetic Diseases, Inborn2
Hypersensitivity2
Hypersensitivity, Immediate2
Immune System Diseases2
Pruritus2
Skin Diseases2
Skin Diseases, Eczematous2

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.